Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Belimed Life Science AG currently has 1 pending office action within the Chemistry & Materials technology area. This action is being handled by 1 distinct examiner, AMIN, JWALANT B, who oversees the total active prosecution for the firm. The matter is located within 1 distinct art unit, indicating a focused technical review within a single specialized division of the patent office.
AMIN, JWALANT B is the busiest examiner for the portfolio, overseeing 1 pending office action. This 1 action constitutes the total active prosecution for the company. With 1 examiner and 1 art unit for the 1 pending action, the prosecution profile is highly centralized. This structure ensures that the company's current chemical and material interests are being evaluated by a single official within a specific technical framework, providing a clear and direct path for the application's progress. Practitioners can focus exclusively on the feedback and requirements of this 1 individual and the standards of the 1 art unit involved. This focused approach simplifies the management of the company's intellectual property and allows for a targeted strategy to resolve the pending office action.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AMIN, JWALANT B | 1 | 79.4% | +15.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18859924 | LOADING METHOD FOR LOADING A WASH RACK, TEST METHOD, AUGMENTED REALITY APPARATUS, LOADING SYSTEM AND CLEANING METHOD | AMIN, JWALANT B | — |
| Art Unit | Apps |
|---|---|
| 1711 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18859924 | LOADING METHOD FOR LOADING A WASH RACK, TEST METHOD, AUGMENTED REALITY APPARATUS, LOADING SYSTEM AND CLEANING METHOD | AMIN, JWALANT B | 1711 | §103 | Final Rejection | — | Pending | Oct 24, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBelimed Life Science AG has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Jwalant B Amin has the most, with 1 of Belimed Life Science AG's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
